A. Aydınlar, "Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF," American Heart Journal , vol.213, pp.35-46, 2019
Aydınlar, A. 2019. Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF. American Heart Journal , vol.213 , 35-46.
Aydınlar, A., (2019). Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF. American Heart Journal , vol.213, 35-46.
Aydınlar, ALİ. "Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF," American Heart Journal , vol.213, 35-46, 2019
Aydınlar, ALİ. "Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF." American Heart Journal , vol.213, pp.35-46, 2019
Aydınlar, A. (2019) . "Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF." American Heart Journal , vol.213, pp.35-46.
@article{article, author={ALİ AYDINLAR}, title={Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF}, journal={American Heart Journal}, year=2019, pages={35-46} }